Back to Search Start Over

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

Authors :
VanderWalde N
Jagsi R
Dotan E
Baumgartner J
Browner IS
Burhenn P
Cohen HJ
Edil BH
Edwards B
Extermann M
Ganti AK
Gross C
Hubbard J
Keating NL
Korc-Grodzicki B
McKoy JM
Medeiros BC
Mrozek E
O'Connor T
Rugo HS
Rupper RW
Shepard D
Silliman RA
Stirewalt DL
Tew WP
Walter LC
Wildes T
Bergman MA
Sundar H
Hurria A
Source :
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2016 Nov; Vol. 14 (11), pp. 1357-1370.
Publication Year :
2016

Abstract

Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with good performance status are able to tolerate commonly used treatment modalities as well as younger patients, particularly when adequate supportive care is provided. For older patients who are able to tolerate curative treatment, options include surgery, radiation therapy (RT), chemotherapy, and targeted therapies. RT can be highly effective and well tolerated in carefully selected patients, and advanced age alone should not preclude the use of RT in older patients with cancer. Judicious application of advanced RT techniques that facilitate normal tissue sparing and reduce RT doses to organs at risk are important for all patients, and may help to assuage concerns about the risks of RT in older adults. These NCCN Guidelines Insights focus on the recent updates to the 2016 NCCN Guidelines for Older Adult Oncology specific to the use of RT in the management of older adults with cancer.<br /> (Copyright © 2016 by the National Comprehensive Cancer Network.)

Details

Language :
English
ISSN :
1540-1413
Volume :
14
Issue :
11
Database :
MEDLINE
Journal :
Journal of the National Comprehensive Cancer Network : JNCCN
Publication Type :
Academic Journal
Accession number :
27799507
Full Text :
https://doi.org/10.6004/jnccn.2016.0146